Access the full text.
Sign up today, get DeepDyve free for 14 days.
Kazuhiko Nakamura, Y. Sekine, Y. Ouchi, M. Tsujii, E. Yoshikawa, M. Futatsubashi, K. Tsuchiya, G. Sugihara, Y. Iwata, Katsuaki Suzuki, Hideo Matsuzaki, Shiro Suda, Toshiro Sugiyama, N. Takei, N. Mori (2010)
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.Archives of general psychiatry, 67 1
Edwin Cook, Ramesh Arora, George Anderson, Elizabeth Berry-Kravis, Shu‐ya Yan, H.C. Yeoh, Paul Sklena, David Charak, Bennett Leventhal (1993)
Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.Life sciences, 52 25
Elissar Andari, J. Duhamel, T. Zalla, Evelyn Herbrecht, M. Leboyer, A. Sirigu (2010)
Promoting social behavior with oxytocin in high-functioning autism spectrum disordersProceedings of the National Academy of Sciences, 107
R. Schain, Daniel Freedman (1961)
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.The Journal of pediatrics, 58
辻 正次 (2010)
論文抄読 Brain Serotonin and Dopamine Transporter Bindings in Adults with High-Functioning Autism, 1
Decreased Brain Serotonin Transporter Binding in ASD [Nakamura et al., 2010 ] Serotonin has been implicated in ASD since the initial report of increased serotonin in the blood of children with ASD in 1961 [Schain & Freedman, 1961 ]. After decades of investigation, the mechanism of the elevation in blood serotonin is not fully understood, although either reduced serotonin 5‐HT2 binding or increased serotonin transporter function were found in hyperserotonemic subjects in one study [Cook et al., 1993 ]. It is important to recognize that the peripheral serotonin increase applies only to a minority of subjects with ASD. Because of challenges in measuring central serotonin function in ASD, there have been few previous studies of serotonin in the brains of individuals with ASD. To date, in vivo study of serotonin in brain has been limited to studies in which radioactively tagged molecules (radioligands) that bind to serotonin proteins (serotonin receptors or transporters) are administered intravenously and taken into the brain where they bind to 5‐HT receptors (e.g. 5‐HT 2 ) or the 5‐HT transporter. SPECT or PET methods are then used to measure binding of the radioligands to the brain serotonin‐related proteins. The authors used the compound [
Autism Research – Wiley
Published: Apr 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.